0001104659-20-095451.txt : 20200814
0001104659-20-095451.hdr.sgml : 20200814
20200814151808
ACCESSION NUMBER: 0001104659-20-095451
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RALLIS CHRIS A
CENTRAL INDEX KEY: 0001185945
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32295
FILM NUMBER: 201104436
MAIL ADDRESS:
STREET 1: C/O TENAX THERAPEUTICS, INC.
STREET 2: ONE COPLEY PARKWAY, SUITE 490
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001211583
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (919) 636-4530
MAIL ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20140903
FORMER COMPANY:
FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC
DATE OF NAME CHANGE: 20021223
4
1
tm2027709d5_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-08-13
0
0001211583
FENNEC PHARMACEUTICALS INC.
FENC
0001185945
RALLIS CHRIS A
68 TW ALEXANDER DRIVE, PO BOX 13628
DURHAM
NC
27709
1
0
0
0
Stock Option (right to buy)
6.17
2020-08-13
4
A
0
20000
0
A
2030-08-13
Common Shares
20000
20000
D
On August 13, 2020, Chris Rallis was granted a non-statutory stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.
The option is 100% vested on the date of grant.
/s/ Chris A Rallis, Chris A Rallis, Director
2020-08-14